IBEX Technologies Inc., a biopharmaceutical company, engages in the production and sale of proprietary enzymes for use as reagents in haemostasis monitoring devices. The company also provides arthritis diagnostic kits for pharmaceutical research. It has operations in Canada, the United States, and Europe. Products Glycobiology / Haematology Enzymes The company produces Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B via a proprietary recombinant expression system. This system allows the production of recombinant forms of these GAG lyases. These enzymes are sold directly to manufacturers of medical devices, quality control labs, and academic research institutions. The company and its partners have developed various diagnostic applications of Heparinase I, principally in the point-of-care market. Key customers include Abbott Point of Care, Medtronic, Siemens, Haemoscope, and Pentapharm. The company also works with third parties in the development of new applications for its glycobiology enzymes. Arthritis Assays The company manufactures and sells arthritis assays, which enable the study of both the synthesis and degradation of cartilage components and are primary tools in the study of osteo and rheumatoid arthritis. Its arthritis diagnostic kits and services are marketed and sold for research use only (RUO) to pharmaceutical companies, clinical research organizations, and academic institutions. The marketing of these diagnostic kits is done directly in North America and through a distributor in Europe. History IBEX Technologies Inc. was founded in 1972.
ibex technologies inc (IBT:Venture)
5485 Pare Street
Montreal, QC H4P 1P7
|No competitor information is available for IBT.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact IBEX TECHNOLOGIES INC, please visit www.ibex.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.